Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
•
Primary Care
In a patient with vaginal itching and a vaginal swab with a positive Candida glabrata NAAT, what is your first-line therapy?
Related Questions
What duration of antibiotic therapy do you use for a loculated parapneumonic effusion that does not meet criteria for empyema?
In light of recent measles outbreaks in the US, would you recommend an MMR booster for an immunocompetent patients born before 1957?
Do you routinely recommend transition to dual PO antibiotic coverage for strep species and MRSA, for patients with purulent cellulitis and in the absence of culture data?
What is your approach to duration of fidaxomicin in a patient receiving treatment for first C difficile infection while also receiving concurrent antibiotics for an infection?
Do you routinely offer suppressive antibiotics to patients with a prosthetic joint infection when surgery is delayed for months?
What factors should guide the choice between fosfomycin and nitrofurantoin for uncomplicated cystitis, given the reduced efficacy of fosfomycin?
Do you recommend boric acid for patients with recurrent candida vulvovaginitis?
Under what circumstances would you treat a patient with an aortic graft infection for greater than 6 weeks of antibiotic therapy, whom has undergone total graft explanation and replacement?
What duration of antibiotics do you use in patients with Actinomyces osteomyelitis, i.e., do you stop after 6 weeks or do you give a longer oral antibiotic course?
Do you recommend lifelong antibiotic prophylaxis, or do you prefer a more selective approach based on risk factors in asplenic patients without a history of severe infections?
